Inflammation in Cerebral Venous Thrombosis
Open Access
- 4 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 833490
- https://doi.org/10.3389/fimmu.2022.833490
Abstract
Cerebral venous thrombosis (CVT) is a rare form of cerebrovascular disease that impairs people’s wellbeing and quality of life. Inflammation is considered to play an important role in CVT initiation and progression. Several studies have reported the important role of leukocytes, proinflammatory cytokines, and adherence molecules in the CVT-related inflammatory process. Moreover, inflammatory factors exacerbate CVT-induced brain tissue injury leading to poor prognosis. Based on clinical observations, emerging evidence shows that peripheral blood inflammatory biomarkers—especially neutrophil-to-lymphocyte ratio (NLR) and lymphocyte count—are correlated with CVT [mean difference (MD) (95%CI), 0.74 (0.11, 1.38), p = 0.02 and −0.29 (−0.51, −0.06), p = 0.01, respectively]. Moreover, increased NLR and systemic immune-inflammation index (SII) portend poor patient outcomes. Evidence accumulated since the outbreak of coronavirus disease-19 (COVID-19) indicates that COVID-19 infection and COVID-19 vaccine can induce CVT through inflammatory reactions. Given the poor understanding of the association between inflammation and CVT, many conundrums remain unsolved. Further investigations are needed to elucidate the exact relationship between inflammation and CVT in the future.Funding Information
- National Natural Science Foundation of China
This publication has 120 references indexed in Scilit:
- Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Polyphosphate: a link between platelets, coagulation and inflammationInternational Journal of Hematology, 2012
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivoThe Journal of Experimental Medicine, 2012
- Innate immunity and coagulationJournal of Thrombosis and Haemostasis, 2011
- Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in miceJCI Insight, 2011
- Toll-Like Receptor 9 Signaling Is Critical for Early Experimental Deep Vein Thrombosis ResolutionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences of the United States of America, 2010
- The InflammasomesCell, 2010
- Roles of Inflammation and the Activated Protein C Pathway in the Brain Edema Associated With Cerebral Venous Sinus ThrombosisStroke, 2010
- Cerebral venous thrombosis: an updateThe Lancet Neurology, 2007